First Nasal Adrenaline Spray Among 10 Products Heading For EU-Wide Approval

 
• By Vibha Sharma

The June meeting of the European Medicines Agency's human medicines committee brought mixed fortunes for companies. 10 new products were recommended for pan-EU approval, two drugs were rejected, while the conditional approval of one drug is set to be revoked. PTC Therapeutics again faced disappointment regarding its Duchenne muscular dystrophy drug Translarna, but has vowed to fight back.

Five hands showing gesture of conformity or disagreement. Horizontal composition.
Opinions Adopted At CHMP’s June Meeting Present A Mixed Bag For Companies • Source: Shutterstock

More from Europe

More from Geography